{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:38:06Z","timestamp":1715906286754},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,16]]},"DOI":"10.7759\/cureus.60417","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:47:13Z","timestamp":1715860033000},"source":"Crossref","is-referenced-by-count":0,"title":["The Potential Risk of Reduced Serum Cholinesterase Activity in COVID-19 Patients Suffering From Cytokine Storm"],"prefix":"10.7759","author":[{"given":"Ghazwan A.","family":"M. Raouf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad K","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muayad A","family":"Merza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040580","article-title":"A comprehensive review of cholinesterase modeling and simulation","volume":"11","author":"De Boer D","year":"2021","unstructured":"De Boer D, Nguyen N, Mao J, Moore J, Sorin EJ. A comprehensive review of cholinesterase modeling and simulation. Biomolecules. 2021, 11:24-6. 10.3390\/biom11040580","journal-title":"Biomolecules"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1389203720666191107094949","article-title":"Butyrylcholinesterase: a multifaceted pharmacological target and tool","volume":"21","author":"Ha ZY","year":"2020","unstructured":"Ha ZY, Mathew S, Yeong KY. Butyrylcholinesterase: a multifaceted pharmacological target and tool. Curr Protein Pept Sci. 2020, 21:99-109. 10.2174\/1389203720666191107094949","journal-title":"Curr Protein Pept Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386454-3.00116-0","article-title":"Cholinesterase inhibition","author":"Wilson BW","year":"2014","unstructured":"Wilson BW. Cholinesterase inhibition. Encyclopedia of Toxicology. 3rd edition. Wexler P (ed): Elsevier, Amsterdam, Netherlands; 2014. 2:942-51. 10.1016\/B978-0-12-386454-3.00116-0"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.8522","article-title":"Dementia prevention and treatment: a narrative review","volume":"184","author":"Reuben DB","year":"2024","unstructured":"Reuben DB, Kremen S, Maust DT. Dementia prevention and treatment: a narrative review. JAMA Intern Med. 2024, 184:563-72. 10.1001\/jamainternmed.2023.8522","journal-title":"JAMA Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114703","article-title":"Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: therapeutic perspectives","volume":"192","author":"Wedn AM","year":"2021","unstructured":"Wedn AM, El-Bassossy HM, Eid AH, El-Mas MM. Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: therapeutic perspectives. Biochem Pharmacol. 2021, 192:114703. 10.1016\/j.bcp.2021.114703","journal-title":"Biochem Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.6637","article-title":"Serum cholinesterase (butyrylcholinesterase) may play a role in body weight homeostasis via the inactivation of ghrelin","volume":"55","author":"Oda E","year":"2016","unstructured":"Oda E. Serum cholinesterase (butyrylcholinesterase) may play a role in body weight homeostasis via the inactivation of ghrelin. Intern Med. 2016, 55:1245. 10.2169\/internalmedicine.55.6637","journal-title":"Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S201594","article-title":"Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction","volume":"12","author":"Han Y","year":"2019","unstructured":"Han Y, Ma Y, Liu Y, et al.. Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction. Diabetes Metab Syndr Obes. 2019, 12:685-702. 10.2147\/DMSO.S201594","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.35975\/apic.v27i3.2244","article-title":"Changes in blood oxidative stress biomarkers and cholinesterase activities after propofol or bupivacaine anesthesia used in women for elective cesarean section delivery","volume":"27","author":"Karam RS","year":"2023","unstructured":"Karam RS, Mohammad FK. Changes in blood oxidative stress biomarkers and cholinesterase activities after propofol or bupivacaine anesthesia used in women for elective cesarean section delivery. Anaes Pain Int Care. 2023, 27:396-404. 10.35975\/apic.v27i3.2244","journal-title":"Anaes Pain Int Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14545","article-title":"Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review","volume":"74","author":"Andersson ML","year":"2019","unstructured":"Andersson ML, M\u00f8ller AM, Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review. Anaesthesia. 2019, 74:518-28. 10.1111\/anae.14545","journal-title":"Anaesthesia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108614","article-title":"Laboratory biomarkers associated with COVID-19 severity and management","volume":"221","author":"Keddie S","year":"2020","unstructured":"Keddie S, Ziff O, Chou MK, et al.. Laboratory biomarkers associated with COVID-19 severity and management. Clin Immunol. 2020, 221:108614. 10.1016\/j.clim.2020.108614","journal-title":"Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59050877","article-title":"COVID-19 biomarkers comparison: children, adults and elders","volume":"59","author":"Capraru ID","year":"2023","unstructured":"Capraru ID, Vulcanescu DD, Bagiu IC, et al.. COVID-19 biomarkers comparison: children, adults and elders. Medicina (Kaunas). 2023, 59:42-4. 10.3390\/medicina59050877","journal-title":"Medicina (Kaunas)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7753631","article-title":"Hematological and biochemical laboratory parameters in COVID-19 patients: a retrospective modeling study of severity and mortality predictors","volume":"2023","author":"Alizad G","year":"2023","unstructured":"Alizad G, Ayatollahi AA, Shariati Samani A, et al.. Hematological and biochemical laboratory parameters in COVID-19 patients: a retrospective modeling study of severity and mortality predictors. Biomed Res Int. 2023, 2023:7753631. 10.1155\/2023\/7753631","journal-title":"Biomed Res Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110557","article-title":"Serum butyrylcholinesterase as a marker of COVID-19 mortality: results of the monocentric prospective observational study","volume":"381","author":"Markuskova L","year":"2023","unstructured":"Markuskova L, Javorova Rihova Z, Fazekas T, et al.. Serum butyrylcholinesterase as a marker of COVID-19 mortality: results of the monocentric prospective observational study. Chem Biol Interact. 2023, 381:110557. 10.1016\/j.cbi.2023.110557","journal-title":"Chem Biol Interact"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.08.021","article-title":"Serum cholinesterase associated with COVID-19 pneumonia severity and mortality","volume":"82","author":"Nakajima K","year":"2021","unstructured":"Nakajima K, Abe T, Saji R, et al.. Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J Infect. 2021, 82:282-327. 10.1016\/j.jinf.2020.08.021","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.940533","article-title":"Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study","volume":"9","author":"Sipahioglu H","year":"2022","unstructured":"Sipahioglu H, Esmaoglu A, Kiris A, Dursun ZB, Kuzuguden S, Cavus MA, Artan C. Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study. Front Med (Lausanne). 2022, 9:940533. 10.3389\/fmed.2022.940533","journal-title":"Front Med (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092150","article-title":"Critically ill COVID-19 patients show reduced point of care-measured butyrylcholinesterase activity-a prospective, monocentric observational study","volume":"12","author":"Espeter F","year":"2022","unstructured":"Espeter F, K\u00fcnne D, Garczarek L, et al.. Critically ill COVID-19 patients show reduced point of care-measured butyrylcholinesterase activity-a prospective, monocentric observational study. Diagnostics (Basel). 2022, 12:54-6. 10.3390\/diagnostics12092150","journal-title":"Diagnostics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.045","article-title":"Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and meta-analysis","volume":"82","author":"Kunutsor SK","year":"2021","unstructured":"Kunutsor SK, Laukkanen JA. Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and meta-analysis. J Infect. 2021, 82:159-98. 10.1016\/j.jinf.2020.05.045","journal-title":"J Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1294904","article-title":"Clinical characteristics and high risk factors of patients with Omicron variant strain infection in Hebei, China","volume":"13","author":"Wang L","year":"2023","unstructured":"Wang L, Liu T, Yue H, et al.. Clinical characteristics and high risk factors of patients with Omicron variant strain infection in Hebei, China. Front Cell Infect Microbiol. 2023, 13:1294904. 10.3389\/fcimb.2023.1294904","journal-title":"Front Cell Infect Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156287","article-title":"Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects","volume":"169","author":"Dharra R","year":"2023","unstructured":"Dharra R, Kumar Sharma A, Datta S. Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects. Cytokine. 2023, 169:156287. 10.1016\/j.cyto.2023.156287","journal-title":"Cytokine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48834","article-title":"Polypharmacy and the in silico prediction of potential body proteins targeted by these drugs among hospitalized COVID-19 patients with cytokine storm","volume":"15","author":"Raouf GA","year":"2023","unstructured":"Raouf GA, Mohammad FK, Merza MA. Polypharmacy and the in silico prediction of potential body proteins targeted by these drugs among hospitalized COVID-19 patients with cytokine storm. Cureus. 2023, 15:e48834. 10.7759\/cureus.48834","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117600","article-title":"Cellular metabolism and health impacts of dichlorvos: occurrence, detection, prevention, and remedial strategies-a review","volume":"242","author":"Saravanakumar K","year":"2024","unstructured":"Saravanakumar K, Park S, Vijayasarathy S, et al.. Cellular metabolism and health impacts of dichlorvos: occurrence, detection, prevention, and remedial strategies-a review. Environ Res. 2024, 242:117600. 10.1016\/j.envres.2023.117600","journal-title":"Environ Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21608\/ejchem.2023.210539.7968","article-title":"In vitro inhibition of blood cholinesterase activities by dichlorvos in farmworkers previously exposed to pesticides","volume":"67581","author":"Odisho SK","year":"2024","unstructured":"Odisho SK, Mohammad FK. In vitro inhibition of blood cholinesterase activities by dichlorvos in farmworkers previously exposed to pesticides. Egyptian J Chem. 2024, 67581:588-9. 10.21608\/ejchem.2023.210539.7968","journal-title":"Egyptian J Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50979","article-title":"Plasma cholinesterase activity in patients with rheumatoid arthritis and toxoplasmosis","volume":"15","author":"Abdullah RG","year":"2023","unstructured":"Abdullah RG, Eassa SH, Mohammad FK. Plasma cholinesterase activity in patients with rheumatoid arthritis and toxoplasmosis. Cureus. 2023, 15:e50979. 10.7759\/cureus.50979","journal-title":"Cureus"},{"key":"ref24","unstructured":"World Health Organization. Global surveillance for COVID-19 disease caused by human infection with novel coronavirus (\u200eCOVID-19)\u200e. interim guidance, 27 February. (2020). Accessed: November 14, 2023: https:\/\/iris.who.int\/handle\/10665\/331231."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218323","article-title":"Preliminary predictive criteria for COVID-19 cytokine storm","volume":"80","author":"Caricchio R","year":"2021","unstructured":"Caricchio R, Gallucci M, Dass C, et al.. Preliminary predictive criteria for COVID-19 cytokine storm. Ann Rheum Dis. 2021, 80:88-95. 10.1136\/annrheumdis-2020-218323","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2022-0215","article-title":"A meta-analysis of normal human blood cholinesterase activities determined by a modified electrometric method","volume":"16","author":"Garmavy HM","year":"2023","unstructured":"Garmavy HM, Mohammed AA, Rashid HM, Mohammad FK. A meta-analysis of normal human blood cholinesterase activities determined by a modified electrometric method. J Med Life. 2023, 16:22-34. 10.25122\/jml-2022-0215","journal-title":"J Med Life"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.22038\/apjmt.2024.74731.1433","article-title":"Determination of glutathione levels and turnover rates in the brain and liver of mice treated with cadmium","volume":"12","author":"Al-Baggou BK","year":"2023","unstructured":"Al-Baggou BK, Mohammad FK. Determination of glutathione levels and turnover rates in the brain and liver of mice treated with cadmium. Asia Pac J Med Toxicol. 2023, 12:103-6. 10.22038\/apjmt.2024.74731.1433","journal-title":"Asia Pac J Med Toxicol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.47108\/jidhealth.Vol5.Iss4.264","article-title":"Blood cholinesterase activities and oxidative stress status among farmworkers using pesticides in Duhok, KRG, Iraq","volume":"5","author":"Odisho SK","year":"2022","unstructured":"Odisho SK, Mohammad FK. Blood cholinesterase activities and oxidative stress status among farmworkers using pesticides in Duhok, KRG, Iraq. J Ideas Health. 2022, 5:786-93. 10.47108\/jidhealth.Vol5.Iss4.264","journal-title":"J Ideas Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46995-y","article-title":"Bedside-measurement of serum cholinesterase activity predicts patient morbidity and length of the intensive care unit stay following major traumatic injury","volume":"9","author":"Zivkovic AR","year":"2019","unstructured":"Zivkovic AR, Schmidt K, Stein T, et al.. Bedside-measurement of serum cholinesterase activity predicts patient morbidity and length of the intensive care unit stay following major traumatic injury. Sci Rep. 2019, 9:10437. 10.1038\/s41598-019-46995-y","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/0885066616636549","article-title":"Value of serum cholinesterase activity in the diagnosis of septic shock due to bacterial infections","volume":"32","author":"Bahloul M","year":"2017","unstructured":"Bahloul M, Baccouch N, Chtara K, et al.. Value of serum cholinesterase activity in the diagnosis of septic shock due to bacterial infections. J Intensive Care Med. 2017, 32:346-52. 10.1177\/0885066616636549","journal-title":"J Intensive Care Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.745515","article-title":"Basic predictive risk factors for cytokine storms in COVID-19 patients","volume":"12","author":"Shcherbak SG","year":"2021","unstructured":"Shcherbak SG, Anisenkova AY, Mosenko SV, et al.. Basic predictive risk factors for cytokine storms in COVID-19 patients. Front Immunol. 2021, 12:745515. 10.3389\/fimmu.2021.745515","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/254222-the-potential-risk-of-reduced-serum-cholinesterase-activity-in-covid-19-patients-suffering-from-cytokine-storm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:47:21Z","timestamp":1715860041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/254222-the-potential-risk-of-reduced-serum-cholinesterase-activity-in-covid-19-patients-suffering-from-cytokine-storm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.60417","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}